4//SEC Filing
Grunberg Gregory 4
Accession 0000899243-19-027222
CIK 0001785173other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 7:04 PM ET
Size
9.9 KB
Accession
0000899243-19-027222
Insider Transaction Report
Form 4
89bio, Inc.ETNB
Grunberg Gregory
Director10% Owner
Transactions
- Conversion
Common Stock
2019-11-13+1,916,787→ 2,491,787 total(indirect: See footnote) - Purchase
Common Stock
2019-11-11$16.00/sh+575,000$9,200,000→ 575,000 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2019-11-13−11,916,667→ 0 total(indirect: See footnote)→ Common Stock (1,916,787 underlying)
Footnotes (3)
- [F1]On November 11, 2019, Longitude Venture Partners III, L.P. ("Longitude Venture III") purchased 575,000 shares of the Issuer's common stock at a price of $16.00 per share in the Issuer's initial public offering.
- [F2]The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-6.217 basis immediately prior the closing of the Issuer's initial public offering on November 13, 2019 and had no expiration date.
- [F3]These shares are held directly by Longitude Venture III. Longitude Capital Partners III, LLC ("Longitude Capital III") is the general partner of Longitude Venture III. The Reporting Person is a member of Longitude Capital III and may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein.
Documents
Issuer
89bio, Inc.
CIK 0001785173
Entity typeother
Related Parties
1- filerCIK 0001711080
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 7:04 PM ET
- Size
- 9.9 KB